Inspection Record

Option Care Enterprises Inc. dba Option Care — FDA 483 Findings

US FDAInspected 2018-03-06Published 2024-01-17 4 findingsAseptic processing and sterility assuranceEquipment and facility

View the regulator's official source The source document is always the basis for judgement.

Findings

1Aseptic processing and sterility assurance

Disinfecting agents, cleaning pads, and cleaning wipes used for sterile drug production were not always sterile or controlled in a manner as to maintain sterility.D isinfecting agents, cleaning pads, and cleaning wipes used for sterile drug production were not always sterile or controlled in a manner as to maintain sterility.

2Equipment and facility

Your facility design allows the influx of poor quality into a higher classified area.

3Aseptic processing and sterility assurance

Poor aseptic practices were observed.

4Aseptic processing and sterility assurance

Media fills were not performed under the most challenging or stressful conditions.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Option Care Enterprises Inc. dba Option Care findings history — including this company's other documents US FDA documents, 2024 Go to Findings search